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A central tenet in support of research reproducibility is
the ability to uniquely identify research resources, i.e.,
reagents, tools, and materials that are used to perform
experiments. However, current reporting practices for
research resources are insufficient to identify the exact
resources that are reported or to answer basic questions
such as “How did other studies use resource X?” To
address this issue, the Resource Identification Initiative
was launched as a pilot project to improve the reporting
standards for research resources in the Methods sections
of articles and thereby improve identifiability and scien-
tific reproducibility. The pilot engaged over 25 biomedical
journal editors from most major publishers, as well as
scientists and funding officials. Authors were asked to
include Research Resource Identifiers (RRIDs) in their
articles prior to publication for three resource types: anti-
bodies, model organisms, and tools (i.e., software and
databases). RRIDs are assigned by an authoritative data-
base, for example, a model organism database for each
type of resource. To make it easier for authors to obtain
RRIDs, resources were aggregated from the appropriate
databases and their RRIDs made available in a central
Web portal (http://scicrunch.org/resources). RRIDs meet
three key criteria: they are machine-readable, free to gen-
erate and access, and are consistent across publishers
and journals. The pilot was launched in February of 2014
and over 300 articles have appeared that report RRIDs.
The number of journals participating has expanded from
the original 25 to more than 40, with RRIDs appearing in
62 different journals to date. Here we present an over-
view of the pilot project and its outcomes to date. We
show that authors are able to identify resources and are
supportive of the goals of the project. Identifiability of
the resources post-pilot showed a dramatic improvement
for all three resource types, suggesting that the project
has had a significant impact on identifiability of research
resources. J. Comp. Neurol. 524:8–22, 2016.
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RESEARCH ARTICLE
Research resources, defined here as the reagents,
materials, and tools used to produce the findings of a
study, are the cornerstone of biomedical research. How-
ever, as has long been bemoaned by database curators
and investigated by Vasilevsky et al. (2013), it is difficult
to uniquely identify these resources in the scientific liter-
ature. This study found that researchers did not include
sufficient detail for unique identification of several key
research resources, including model organisms, cell lines,
plasmids, knockdown reagents, or antibodies. In most
cases, authors provided insufficient metadata about the
resource to conclusively identify the particular resource,
e.g., a nonunique set of attributes with no catalog or
stock number. It should be noted that the authors were,
generally speaking, following the reporting guidelines
offered by the journals. Such guidelines traditionally state
that authors should include the company name and city
in which it was located for the resources used in the
study. Further, even when uniquely identifying informa-
tion was provided (e.g., a catalog number for a particular
antibody), the vendor may have gone out of business, the
particular product may no longer be available, or its cata-
log information may have changed. Given that in these
cases a human cannot find which resources were used,
an automated agent, such as a search engine or text min-
ing tools, will also not be able to identify the resources.
Because current practices for reporting research
resources within the literature are inadequate, nonstan-
dardized, and not optimized for machine-readable
access, it is currently very difficult to answer very basic
questions about published studies such as “What stud-
ies used the transgenic mouse I am interested in?”
These types of questions are of interest to the biomedi-
cal community, which relies on the published literature
to identify appropriate reagents, troubleshoot experi-
ments, and aggregate information about a particular
organism or reagent to form hypotheses about mecha-
nism and function. Such information is also critical to
funding agencies that funded a research group to gen-
erate a particular tool or reagent; and the resource pro-
viders, both commercial and academic, who would like
to be able to track the use of these resources in the lit-
erature. Beyond this basic utility, identification of the
particular research resource used is an important com-
ponent of scientific reproducibility or lack thereof.
The Resource Identification Initiative (RII) is laying the
foundation of a system for reporting research resources in
the biomedical literature that will support unique identifi-
cation of research resources used within a particular
study. The initiative is jointly led by the Neuroscience
Information Framework (NIF; http://neuinfo.org) and the
Oregon Health & Science University (OHSU) Library, data
integration efforts occurring as part of the Monarch Initia-
tive (www.monarchinitiative.org), and with numerous
community members through FORCE11, the Future of
Research Communications and e-Scholarship, which is a
grassroots organization dedicated to transforming schol-
arly communication through technology. Since 2006, the
NIF has worked to identify research resources of rele-
vance to neuroscience. The OHSU group has long-
standing ties to the model organism community, which
maintains databases populated by curating the literature
and contacting authors to add links between model organ-
isms, reagents, and other data. In a 2011 workshop (see
https://www.force11.org/node/4145) held under the
auspices of the Linking Animal Models to Human Diseases
(LAMHDI) consortium, various stakeholders from this
community drafted recommendations for better reporting
standards for animal models, genes, and key reagents.
The RII initiative was launched as a result of two plan-
ning meetings building off of the recommendations of the
LAMHDI workshop. The first was held in 2012 at the Soci-
ety for Neuroscience meeting with over 40 participants
comprising editors, publishers, and funders (sponsored
by INCF; http://incf.org). This meeting outlined the prob-
lem of incomplete identification of research resources
within articles, and the need for a computational solution
for identifying and tracking them in the literature. Recog-
nizing that any solution needed to work for both humans
and machines, three broad requirements were identified:
1) the standard should be machine-processable, that is,
designed for search algorithms, in addition to human
understanding; 2) the information should be available
outside the pay wall, so that search algorithms and
humans have free access to the information across the
biomedical literature; and 3) the standard should be uni-
form across publishers, to make uptake and usage easier
for both human and machines.
A follow-up workshop at the NIH (https://www.force11.
org/node/4857) was held in June of 2013 to gain agree-
ment from this stakeholder group for the design of a pilot
that would explore solutions for this problem. A working
group, the Resource Identification Initiative, was estab-
lished through FORCE11 comprised of publishers, journal
editors, antibody manufacturers and distributors, biocura-
tors, software tool developers, and foundations. Based on
agreements garnered at the June 2013 meeting, the RII
designed a pilot project to test implementation of a system
for authors submitting manuscripts to identify research
resources through the use of a unique identifier, termed a
Research Resource Identifier (RRID).
PILOT PROJECT OVERVIEW
The pilot project limited its focus to three types of
resources: primary antibodies, noncommercial software
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tools/databases, and model organisms. These were
chosen because they are a major source of variation
across experiments and are used broadly across bio-
medical research communities. For the purposes of this
pilot, a critical aspect was that a relatively complete
and authoritative central registry existed that could
issue an accession number, as GenBank does for gene
sequences. To gain broad agreement among publishers
and editors who were concerned about the potential
burden on authors and staff, it was agreed that partici-
pation in the pilot project would be voluntary for
authors, with participation not representing a condition
of acceptance for publication. The pilot project was
also designed to have minimal requirements for publish-
ers such that modification of manuscript submission
systems was not required.
The pilot project was originally designed to run for 6
months, with each of the participating journals agreeing to
participate for at least 3 months. The goal was to ensure a
large enough sample to understand author behavior: could
they and would they do the task, and to obtain sufficiently
large participation to demonstrate the utility of RRIDs. Over
the minimum 3-month window, each partner journal would
request authors to supply RRIDs in a standard format as a
citation to indicate the use of antibodies, software and
databases, and model organisms. To be as unambiguous
as possible, authors were to include the RRIDs for resour-
ces that were utilized in the study and described in the text
of the Materials and Methods, but not in the Introduction
or Discussion sections, where they might be mentioned in
passing but not used in the study. The RRID syntax com-
prises an accession number assigned by the authoritative
database with the prefix “RRID:” prepended (e.g., RRI-
D:AB_2298772 for an antibody). We also requested that
non-open-source journals include RRIDs in the keyword
field, as this field is available for indexing in PubMed out-
side of pay-walls. The journals were given flexibility for
when and how they wanted to ask authors for these identi-
fiers, namely, at time of submission, during review, or after
acceptance. They were not required to modify their instruc-
tions to authors or their submission systems. The RII team
would be responsible for preparing appropriate materials
for requesting RRIDs and for establishing a central portal
where these identifiers could be obtained. The RII team
also agreed to establish a help desk to assist the authors if
they encountered any difficulties.
The pilot project was designed to address four key
questions. A set of evaluation criteria was designed for
each question:
1. Participation: Would authors be willing to add resource
identifiers to their publications and register new
resources in the system? Participation was evaluated
by examining the number of submissions to the partici-
pating journals, the rate of author participation in pro-
viding RRIDs, the number of new resources registered,
and direct feedback from authors.
2. Performance: Could authors add these identifiers cor-
rectly or would additional editorial or staff oversight be
necessary? Performance was measured by a quantita-
tive analysis of RRID correctness by RII curators.
3. Identifiability: Would the use of RRIDs improve our
ability to identify resources in the literature? Identifi-
ability was measured both pre- and post-pilot in the
journals that participated.
4. Utility: Will RRIDs be useful to the scientific commu-
nity? Can the RRIDs as constructed be used to identify
all studies that use a particular research resource? To
encourage the development of applications, the data-
set is being made freely available so that third parties
can develop tools to work with RRIDs.
The pilot began in February 2014, with over 25 jour-
nals participating. Journals that sent a letter to authors at
some stage of the review process included: Journal of
Neuroscience, Brain and Behavior, Journal of Comparative
Neurology, Brain Research, Experimental Neurology,
F1000Research, PeerJ, Journal of Neuroscience Methods,
Neurobiology of Disease, and the Frontiers group of jour-
nals. One journal, Neuroinformatics, chose to add the
RRIDs to all manuscripts before asking authors to do
this. Journals in the Elsevier and BMC groups were partic-
ipants based on updates to their instructions to authors.
Because of the success of the project, it was subse-
quently extended and is still active as of this writing. The
number of journals participating has expanded, and now
includes PLoS Biology and PLoS Genetics as well as multi-
ple immunology journals in the Elsevier family. A list of
the participating journals is available on the Force11
Website (https://www.force11.org/RII/SignUp).
One of the primary requirements of the pilot project
was to make it as easy as possible for authors to
obtain the appropriate identifiers and insert them cor-
rectly into their manuscripts. As noted above, the three
research resources were chosen because each was
covered by an authoritative database (Table 1) that
assigned unique IDs and a standard set of metadata to
each. However, as can be seen by the length of the list
in Table 1, authors could potentially be required to visit
several databases to obtain the appropriate identifiers.
To simplify this process, we established a Resource
Identification Portal based on the SciCrunch platform,
which leverages data aggregation performed by the
DISCO aggregation engine (Marenco et al., 2014;
http://scicrunch.org/resources; Fig. 1). The portal
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provides a unified query across different resource data-
bases and displayed the results in a common format.
The portal allows search on various facets such as
resource name, catalog number, etc. There is a “cite
this” link that provides the citation, as it should be
reported in the article. The citation generally includes
not just the RRID, but a set of appropriate metadata that
would identify the vendor and catalog number as well, for
example: A polyclonal antibody against tyrosine hydroxy-
lase (TH) (Chemicon, Cat. AB1542, RRID:AB_90755).
METHODS
SciCrunch was built based on the extensible Neuro-
science Information Framework platform described previ-
ously (Gardner et al., 2008; Marenco et al., 2014; RRID:nif-
0000-25673), and the portal infrastructure for RII was
developed under an award from NIDDK to create a dkNET
portal (RRID:nlx_153866), while the customization of the
portal was done by Monarch staff. The data are aggre-
gated from the SciCrunch tool registry, the antibody regis-
try, as well as the model organism community databases
TABLE 1.
Source Databases and Registries Included in the RII Portal
Resource name Resource content Database identifier
ZIRC, Zebrafish Resource Center Zebrafish stocks RRID:nif-0000-00242
ZFIN, Zebrafish Information Network Zebrafish nomenclature RRID:nif-0000-21427
RGD, Rat Genome Database Rat RRID:nif-0000-00134
CGC, Caenorhabditis Genetics Center Worm stocks RRID:nif-0000-00240
WormBase Worm nomenclature RRID:nif-0000-00053
IMSR, International Mouse Strain Resource Center Mouse stocks RRID:nif-0000-09876
BDSC, Bloomington Drosophila Stock Center Fly stocks RRID:nif-0000-00241
MGI, Mouse Genome Informatics Mouse nomenclature RRID:nif-0000-00096
BCBC, Beta Cell Biology Consortium Mouse stocks RRID:nlx_144143
antibodyregistry.org, Antibody Registry Antibodies RRID:nif-0000-07730
SciCrunch Registry Software tools and databases RRID:nlx_144509
Each database has a weekly or monthly scheduled frequency of update and all new data are released weekly. If available, data from both model
organism authorities is served, as well as the list of strains available via particular stock centers. In most cases the stock centers maintain a link
between the genotype and the stock center animal identifier.
Figure 1. The Resource Identification Initiative portal containing citable Research Resource Identifiers (RRIDs). The workflow for authors is
to visit http://scicrunch.org/resources, then select their resource type (see community resources box), type in search terms (note that
the system attempts to expand known synonyms to improve search results), and open the “Cite This” dialog box. The dialog shown here
displays the Invitrogen catalog number 80021 antibody with the RRID:AB_86329.
Resource Identification Initiative
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and stock centers (Table 1). The data infrastructure allows
curators to keep indexes synchronized with the source
databases by using an automated crawling engine and
new data are released on a weekly basis. All open data
from each of these databases is available to download
from the source sites, where update frequencies are
listed.
The journal editors were provided with recommended
instructions to authors (the instructions to authors are
available here: https://www.force11.org/node/4856).
For antibodies, we only required authors to identify pri-
mary antibodies and not secondary or tertiary com-
plexes. For software tools and databases we focused
on freely available and generally publicly funded non-
commercial tools. For model organisms, we focused on
the five commonly used organisms: mouse, rat, zebra-
fish, fruit fly, and worm. Authors were asked to insert
the correct citation for the resource into the text of the
Materials and Methods section and in the keywords. A
help desk was established by the RII working group
that provided help if an author encountered difficulty. In
most cases, requests were handled in less than 24
hours.
If a resource was not found via the portal, authors
were given the option to submit the resource to obtain
an identifier. For antibodies and software/databases,
which are found in databases maintained within the NIF,
submission was handled through the Resource Identifica-
tion Portal. For model organisms, the author was
referred to the authoritative model organism database
for their organism (RGD, MGI, ZFIN, Wormbase, or Fly-
base). All new submissions were curated by their respec-
tive databases and the data were pulled back into the
RII portal weekly so that authors could see their newly
registered resources in approximately a week.
To evaluate the aims of the pilot project, we tracked
the use of RRIDs in published articles and journals. We
performed an in-depth analysis of the first 100 articles
found through Google Scholar that reported RRIDs. For
each article, we examined the Methods section to
determine the correct usage (i.e., if the RRID pointed to
the correct resource), the syntactic correctness (i.e., if
the author reported the RRID using the correct syntax),
and the identifiability of the three resource types. The
total number of research resources reported in the first
100 articles reporting RRIDs was determined by manual
inspection of each article by two independent curators.
A Google Scholar alert was used to track all new
articles that contained an RRID, using the search
“RRID:”. Each of the first 100 articles was downloaded
and examined for the snippets of text surrounding
research resources (in the Methods or Data Use
sections).
Curation workflow to determine correct
usage of reported RRIDs
To determine if the RRIDs were reported correctly for the
three resource types, the following criteria were applied.
 A resource was considered correct if resource
reported an RRID and that RRID pointed to the cor-
rect resource in the RII portal. This determination
was made both by manual search of the RII portal
and via the SciCrunch resolving service for each
reported RRID (for example, https://scicrunch.org/
resolver/RRID:AB_262044).
 A resource was considered incorrect if the reported
RRID pointed to a different or nonexising resource in
the RII portal or SciCrunch resolving service.
 A resource was considered to have the correct syn-
tax if the resource reference contained an RRID, and
the RRID was formatted correctly, had no missing
characters or other typos.
Curation workflow for identifiability of the
three resource types
To determine if the three resource types were identi-
fiable in the journal articles that reported RRIDs (post-
pilot), and in articles from the same journals before the
pilot started. To select the pre-pilot articles, articles
were selected by performing a PubMed search filtered
for each journal and using the first five publications
returned that contained the relevant resource types
from approximately January–March 2013. The following
criteria were applied: Resources (primary antibodies,
organisms, and noncommercial tools) were considered
identifiable if they contained an accurate RRID or by
using the same specific resource identification criteria
as described in Vasilevsky et al. (2013). Noncommercial
software and databases that were not previously ana-
lyzed were considered identifiable if they contained the
correct RRID or reported the manufacturer and version
number for that tool. Note that we distinguished com-
mercially produced for-profit software from public or
individually produced software (noncommercial).
Statistical analysis for identifiability of the
three resources
Since the data were binomial in that each resource
was either identifiable or not, we used a binomial confi-
dence interval strategy for calculating upper and lower
95% confidence intervals (CI) (http://www.danielsoper.
com/statcalc3/calc.aspx?id=85, RRID:SCR_013827). Error
bars for the corresponding 95% CI are displayed on the
graphs. Statistical significance was determined by calcu-
lating the z-score.
A. Bandrowski et al.
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RESULTS
The first RRIDs began appearing in the literature in April
of 2014. Although the first article was identified through
PubMed, the majority of articles were found via Google
Scholar by searching for “RRID.” Google Scholar, unlike
PubMed, appears to search the full text of articles, as it
returns snippets of text from the materials and methods
containing the RRIDs (for example, Fig. 2). A search in
PubMed returns very few articles, indicating that most
journals were not including the RRIDs outside of the pay-
wall. As these articles start to appear in PubMed Central,
where full text search is possible, we anticipate that more
articles utilizing RRIDs will be identifiable through the
National Library of Medicine. Google Scholar possesses
the advantage in that it obtains articles without an
embargo period and makes them available for search
immediately at the time of publication. In this article, we
therefore present analysis based on Google Scholar.
Search via Google Scholar reveals that the RRID pre-
fix is not a unique string, but is an acronym for several
entities, most commonly the Renal Risk in Derby clini-
cal study (for example, McIntyre et al., 2012). To return
examples of RRIDs requires the use of additional filters,
e.g., restricting search to the years 2014 and later. The
combination of the RRID prefix with the resource acces-
sion number is unique, however, in that searching for a
particular RRID, for example RRID:AB_90755, returns
only articles that use this research resource (Fig. 2).
The first 100 articles were published in 16 journals
and included 562 RRIDs reported by authors. The bulk
of the identifiers (490) came from two journals, the
Journal of Comparative Neurology (JCN) and the Journal
of Neuroscience, as these two journals were first to par-
ticipate, both starting the pilot in early February of
2014.
Outcome #1: Participation
As of March 1, 2015 there were 312 articles pub-
lished with at least one RRID, from 44 unique journals
(Supplementary Table 1 shows the updated list of
Figure 2. RRIDs found in the published literature. Google Scholar result for the anti-tyrosine hydroxylase antibody RRID (9/2014; http://
scholar.google.com/scholar?q=RRID:AB_90755) and the most frequently reported RRIDs in the first 100 articles, by number of articles
using the identifier. All data are available in the Supplementary Table and all identifiers can be accessed in Google Scholar (see also Sup-
plemental Table).
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journals and a count for each), indicating that hundreds
of authors have participated in the pilot project even
though it is voluntary. Table 2 shows the different
mechanisms and timing of contact for authors by differ-
ent journals. Informal feedback from the editors and
authors via the help requests and other correspondence
indicates that authors who are attempting to find RRIDs
are supportive of the aims of the project and readily
able to find the correct RRIDs.
One journal, the Journal of Neuroscience, sent
authors letters asking for their participation during dif-
ferent periods of the publication cycle. There did not
appear to be a more advantageous time for the corre-
spondence. The Journal of Comparative Neurology
directly assisted authors during different periods of the
publication cycle and had excellent participation. The
high rate of compliance is likely due to the direct assis-
tance but also to the publication of an editorial to sup-
port awareness (Bandrowski et al., 2014) and a long-
standing history of antibody identification back to
2006. Neuroinformatics has section for tools, and sev-
eral articles incorporated RRIDs even prior to staff look-
ing them up. The Journal of Comparative Neurology also
has such a section and antibodies.
Authors were willing to add resources to the regis-
tries if they were not available. We analyzed the statis-
tics for the Antibody Registry and SciCrunch Tool
Registries, as we had programmatic access to these.
TABLE 2.
Journal Practices in Contacting Authors
Journal Submission Review Acceptance Compliance Notes
Journal of Neuroscience Letter (1175) Letter (163) Letter (26) 12% Asking at different stages has no effect
on rate of compliance
Journal of Comparative
Neurology
Working with
Author
Working with
Author
Working with Author >90% Published an editorial and has a history
of proper antibody identification back
to 2006
Brain and Behavior Letter (100) 25% Letters started to be sent out in April
2014, at times the editor followed up
with authors, did not keep exact
records
Neuroinformatics Staff looks up data 100% Journal has a section for tools used in
the study, which now includes RRIDs,
several papers incorporated RRIDs
prior to staff intervention
F1000 Research Letter (50) 12% Approximate figure from editor
Brain Research Letter (671) 1% Authors receive automatically generated
letters with multiple instructions,
including RII guidelines. Authors are
asked to incorporate RRIDs or
database identifiers (overall
compliance 1%; for RRIDs< 1%).
Journal of Neuroscience
Methods
Letter (314) 1% Authors receive automatically generated
letters with multiple instructions,
including RII guidelines. Authors are
asked to incorporate RRIDs or
database identifiers (overall
compliance 1%; for RRIDs< 1%).
Neurobiology of Disease Letter (291) 3% Authors receive automatically generated
letters with multiple instructions,
including RII guidelines. Authors are
asked to incorporate RRIDs or
database identifiers (overall
compliance 3%; for RRIDs 2%).
Experimental Neurology Letter (297) 3% Authors receive automatically generated
letters with multiple instructions,
including RII guidelines. Authors are
asked to incorporate RRIDs or
database identifiers (overall
compliance 3%; for RRIDs< 1%).
Different journals chose to contact authors at different stages of the publishing cycle and assist in the addition of RRIDs via different mechanisms.
The participation rate was by far the lowest with only instructions to authors; these journals are not included in this table (for example BMC) and
had< 1% participation rates. When authors were asked by a blanket mailing containing instructions, participation rates ranged between 1 and 15%.
Participation was very high if the editorial staff asked authors directly or suggested identifiers for their manuscript. Note that in some cases only
an approximation could be made by the participating journals.
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Since the project began, over 200,000 antibodies from
vendors, both solicited and unsolicited, and at least
200 from individual authors were added to the Antibody
Registry (antibodyregistry.org). In cases where antibod-
ies are sold by government-led projects such as Neuro-
Mab from UC Davis, antibody identifiers have been
included in the antibody manufacturer’s Website. Many
of the additions were secondary antibodies, which were
not part of the pilot project but authors felt that they
should also be identified. In one representative exam-
ple, Jackson ImmunoResearch was contacted by several
authors and subsequently submitted their full catalog to
the Antibody Registry, allowing authors to report RRIDs
for their secondary antibodies. Additionally, there were
over 100 software tools and databases registered.
Many were for common commercial statistical tools
(e.g., SPSS, GraphPad), technically out of scope for the
pilot project, but authors did not make the distinction
between commercial and noncommercial tools. A com-
parison of new resources added versus those reported
in the first 100 articles indicates that the Registries
already listed the majority of research resources in
each of these categories, as the number of new resour-
ces added for this set represented only 10% of the
total reported resources.
Figure 2 shows the most common tools identified by
RRID in articles from the first 100 articles. Commercial
tools such as MatLab, SAS, and GraphPad were cited
along with noncommercial tools such as ImageJ and
FreeSurfer. The most common antibody was the anti-
NeuN antibody from Millipore, now Merck. These same
resource identifiers have continued to be very highly
cited in subsequent articles, with ImageJ cited in 42
articles and the NeuN antibody cited in 8 articles (Goo-
gle Scholar March 17, 2015).
Outcome #2: Performance
A major concern of the publishers and editors was
whether or not authors could retrieve RRIDs correctly
and whether significant editorial oversight would be
necessary for quality control (see workshop outcome
documents at https://www.force11.org/node/4857).
To determine if authors were correctly reporting
RRIDs, we analyzed the reported RRIDs and determined
if they pointed to the correct resources in the RII por-
tal, by comparing the metadata and RRID reported for
each resource using the resolving service (for example,
see https://scicrunch.org/resolver/RRID:AB_262044)
or by querying the portal. Overall, 96% (538/562) of
the RRIDs reported by authors were correct (i.e., the
RRID pointed to the correct resource). More specifi-
cally, 96% of antibodies (413/429), 87% of organisms
(48/55), and 99% of tools (77/78) were correctly
reported (Fig. 3).
Inspection of the 16 errors in reporting RRIDs for anti-
bodies (4% error rate) showed that three errors were
copy/paste mistakes where authors mixed up the combi-
nation of catalog number and identifier for resources
used in their article; three errors resulted from identifiers
missing a digit at the end of the ID (for example, “Swant,
catalog #6B3, RRID: AB_1000032” should have been
labeled RRID: AB_10000320); and one error involved
reporting a reference PMID instead of the resource identi-
fier. The apparent cause of the other antibody errors was
not possible to determine. For organisms, seven errors
were made (13% error rate). All of these errors involved
mice for which authors used the appropriate gene or
allele identifier from Mouse Genome Informatics (MGI),
rather than the stock number or genotype identifying the
organism. It should be noted that MGI as of 2015 can
search the genotypes, but at the time of the pilot project
the search was limited to alleles, thus it stands to reason
that authors went to MGI as opposed to the SciCrunch
portal to identify resources. The fewest errors were made
in identifying software tools and databases, with only one
mistake from 78 total (1% error rate). The mistake was
made as the author apparently used an antibody identi-
fier instead of a tool identifier.
The use of a unique string to retrieve RRIDs is aided
by a common syntax. In our analysis of RRIDs we also
noted whether or not the RRID was correctly formed. In
66% (369/562) of cases the RRID was reported with
the correct syntax, 63% of antibodies, 85% of
Figure 3. Percent correctly reported RRIDs. The percentage of
resources that reported an RRID that pointed to the correct
resource and with the correct syntax for each resource type is
shown. The total number of resources for each type during the
post-pilot is: primary antibodies, n5 429; organisms, n5 55;
noncommercial tools, n5 78.
Resource Identification Initiative
The Journal of Comparative Neurology | Research in Systems Neuroscience 15
organisms, and 67% of tools were formatted correctly
(Fig. 3). The most common variant was the addition of
extra spaces (RRID:AB_90755 vs. RRID: AB_90755),
with 67% (129/193) of the minor corrections being due
to an extra space. Other common variants were failure
to include the RRID prefix, using various symbols or
spaces in the identifier, or splitting up the RRID prefix
and identifier in a table. Authors did not create RRIDs
for resources they were either unable to find or were
not in the portal in 142 cases, which constitutes an
overall 20% false-negative rate (36/465 reported anti-
bodies were false negatives 8%, 84/139 reported
organisms were false negatives 60%, and 22/101 tools
22% were false negatives). In other words, authors
included RRIDs for the appropriate resource in over
80% of cases.
Outcome #3: Identifiability
An outcome of this study was to determine if the use
of RRIDs in the literature increased the identifiability of
research resources. As shown in Fig. 4, when authors
were asked by their editors to provide RRIDs, regard-
less of their compliance with the RII project, the identi-
fiability of research resources significantly increased.
We calculated the percentage of identifiable research
resources in the same journals, just before the pilot
project and after. The reporting of research resources
pre-pilot was consistent with findings from the 2013
study (Vasilevsky et al., 2013), in that roughly 50–60%
were found to be identifiable. But when asked by their
editors, researchers used identifying information in 80–
90% of research resources, showing that they presum-
ably had the data available, but did not put it into their
articles unless prompted by communication from the
editors.
Outcome #4: Utility
Machine-processability
The ability to search all studies that used a particular
research resource was a prime motivation for this pilot.
The current project had a loose definition of “machine-
processable” because we did not want to impose any
requirements on the publishers to modify their journal
submission system for a pilot. Thus, we opted to craft
RRIDs as unique, indexable alphanumeric strings based
on authoritative sources that could support use of Web
search engines to return articles using a particular
research resource. We specifically asked authors to
assess resources mentioned in the Materials and Meth-
ods section where they would normally provide identify-
ing information, because we wanted to track actual use
of the resource and not just mentions.
For individual RRIDs the approach was highly suc-
cessful, as illustrated by the ability to type a particular
RRID into three search engines for the biomedical liter-
ature: Google Scholar, PubMed, and Science Direct and
retrieve appropriate articles, e.g., RRID:AB_90755 or
AB_2298772 (for Google Scholar, see Fig. 2). It is
important to note that each of these systems will come
back with different results because each search tool
has different types of data about each article. For
example, ScienceDirect has a good full text search of
all Elsevier content, but it does not search other pub-
lisher’s content. Both PubMed and Scopus search only
the abstracts and return a subset of articles where
authors followed instructions to add RRIDs to the key-
words, but not those that are only in the Methods sec-
tion. Google Scholar is the most comprehensive, as it
appears to search full text and brings back articles that
are both published and unpublished (usually these are
accepted for publication, but not yet indexed by
PubMed). An analysis performed in October 2014
showed varying results from each search engine: Goo-
gle Scholar returned 315 results (from 2014, 174 are
true RRIDs), and ScienceDirect returned 18 (from 2014,
three are RRIDs). PubMed revealed 23 articles that con-
tained RRIDs (from 2014, all identify the resource iden-
tification initiative identifiers). Scopus returned 48
documents (from 2014, 18 are RRIDs).
Figure 4. Pre- and post-pilot identifiability. Resources (primary
antibodies, organisms, and tools) were considered identifiable if
they contained an accurate RRID or by using the same criteria as
described in Vasilevsky et al. (2013). For tools (software and
databases, which were not previously analyzed), these resources
were considered identifiable if they contained an RRID or
reported the manufacturer and version number. The total number
of resources for each type is: primary antibodies pre-pilot,
n5 140; primary antibodies post-pilot, n5 465; organisms pre-
pilot, n5 58; organisms post-pilot, n5 139; noncommercial tools
pre-pilot, n5 59; noncommercial tools post-pilot, n5 101. The
y-axis is the average percent identifiable for each resource type.
Variation from this average is shown by the bars: error bars indi-
cate upper and lower 95% confidence intervals. Asterisks indicate
significant difference by a z-score greater than 1.96.
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To promote the development of third-party tools
around RRIDs, we created a resolver service for RRIDs
using SciCrunch. Typing http://scicrunch.com/resolver/
RRID:AB_90755 will resolve to a landing page with meta-
data on a particular entity. The resolving service allows
applications to make use of RRIDs to, for example, enhance
articles with RRIDs by providing additional information
about the entity and link to relevant articles and resources.
For instance, Elsevier has released their antibody applica-
tion, which displays antibody metadata in the right-hand
side panel, next to the article (see Fig. 5 for a screen shot
for MacLaren et al., 2015: http://www.sciencedirect.com/
science/article/pii/S0306452214008458). The reader can
browse through antibodies referred to in the article, view
complete records in antibodyregistry.org, and access addi-
tional information via direct links to GenBank, ZFIN, and
other relevant databases. The application also recommends
the three most relevant articles published in Elsevier jour-
nals that refer to the same antibody. The application is
freely available on ScienceDirect.
Publication practices
Non-open-access journals were asked to add RRIDs to
publication keywords, but our initial findings suggest
that this practice was not being consistently followed.
Only 23 articles of 41 total (as of October 20, 2014)
were accessible in PubMed. Additionally, it should be
noted that in two cases identifiers were removed at
typesetting after the initial online version of the article
was published with the RRIDs. These identifiers were
removed not only from the article, but also from
PubMed keywords. Although this was reversed when
noted by the working group, this demonstrates that
successful implementation requires knowledge of the
RRIDs and agreement by the publishers at all steps.
DISCUSSION
The pilot RRID project has been highly successful in
demonstrating the utility of a system to aid in the identifi-
cation of antibodies, software and databases, and model
organisms in the biomedical literature. We showed that
authors were willing to adopt new styles of citation for
research resources that promoted more accurate identifi-
cation of research resources used in a study, and that
were more amenable to machine-based identification. To
date, RRIDs have appeared in over 400 articles from 60
journals. With one exception (the Journal of Neuroscience),
journals have continued their request for RRIDs beyond
the initial 3-month pilot project and new journals have
signed up beyond the initial set that started the project.
We believe that the success of the project was due to the
extensive preplanning that involved the publishers and the
editors, the limited scope of the initial request, and the
recognized need by researchers for better and more useful
reporting standards for research resources.
The load on curation staff with participating journals
has been minimal and the initial portal prototype appears
reasonable for the majority of authors to find their
resource identifiers. With >10,000 searches in the RII
portal, there were 100 help questions. Many of these
questions were about scope, i.e., whether a particular
research resource should be identified, others were for
assistance in finding a resource or guidance in adding a
resource not yet contained in the community authorities.
While this is not a large number, it is also not insignifi-
cant, particularly as the project expands, and certainly
points out the need for specific help functions.
Given the relative completeness of the registries and
the rapid advance of machine-learning based techni-
ques for entity recognition, we can envision a semiauto-
mated system that assists the author in supplying
correct IDs. We have already improved our ability to
detect digital research resources in the literature using
machine learning (Ozyurt et al., in review, PLoS One). In
this system, machine learning is used to identify soft-
ware tools and databases in text and compare the
information to Registry listings. The development of
such functions would allow the development of recom-
mender systems for authors and automated fact check-
ers for journal staff.
Why unique identifiers?
Unique identifiers serve as a primary key for identify-
ing a given research resource and providing the ability
for search engines to parse them is paramount. Unique
identifiers enable disambiguation of entities with similar
labels. The ID should not point to two different entities
and needs to be persistent, that is, they need to outlive
the entity itself. They also need to be at least minimally
machine-processable. While many authors supplied
identifying information like the catalog number for an
antibody supplied by the vendor, or the official strain
nomenclature supplied by the IMSR for a mouse, nei-
ther of these served the required functions. A catalog
number is not a unique identifier, but rather a useful
way for vendors to identify their products. If different
vendors sell the same antibody, it will have different
catalog numbers. If the same antibody is sold in differ-
ent aliquots, it may have different catalog numbers.
When the antibody is no longer available, the catalog
number may disappear, or in some cases it may be
reassigned to another antibody. All of these features
are undesirable in an identifier system. The Antibody
Registry, in contrast, was specifically designed to sup-
ply useful and stable identifiers for antibodies and not
Resource Identification Initiative
The Journal of Comparative Neurology | Research in Systems Neuroscience 17
as a commercial source of antibodies. Similarly, the
strain nomenclature developed by the Jackson Labora-
tory, with its superscripts and special characters, is
useful for human curators to identify a particular strain,
but causes hiccups in most search engines because of
all of the special characters. We believe that a well-
curated registry is essential to the success of such a
system, because of the necessity of these two func-
tions, which currently cannot be replaced with a simple
uncurated registration service. For example, we found
in the registries we maintain, both software or antibod-
ies, that authors sometimes register an entity that is
found by a curator to be a duplicate.
Reporting of RRIDs
When considering accuracy and syntax, the majority
of the issues were due to minor syntax errors (33% of
RRIDs had a syntax error), and a minority of the resour-
ces (4%) was incorrectly reported. The data suggest
authors are able to find the correct RRID for their
resource, but the higher syntax error rate indicates a
need for an improved process for reporting the RRIDs
in the manuscripts. Typesetting may cause some of the
syntax issues, for example, spaces may be introduced,
especially when the RRID is at the end of a line. Addi-
tionally, these types of syntax errors are resolvable by
the resolver, so they do not pose an issue for the
machine readability.
Authors included RRIDs for the appropriate resour-
ces in 80% of the articles. This analysis did not allow
us to determine if authors did not report RRIDs
because the resource was not available in the RII por-
tal at the time, or if they failed to include the RRID for
another reason.
Figure 5. An exemplar third-party application using the RRID resolving service. The “Antibody data for this article” application developed
by Elsevier enhances articles on ScienceDirect. The application is available in 211 articles in 19 journals (more information can be found
at: http://www.elsevier.com/about/content-innovation/antibodies).
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The analysis for this pilot project focused on primary
antibodies and noncommercial tools; however, many
authors included RRIDs for secondary antibodies and
commercial tools, such as MatLab or SAS. While this
was out of the scope for this analysis, this indicates
that authors are willing and eager to provide RRIDs for
additional research types, not just those included in
this pilot project.
In two articles, authors reported RRIDs for resources
that were not used as part of the study, but rather
were discussed in the Introduction or Discussion sec-
tions. A goal of this study is to enable one to determine
the usage of a particular resource, as reported in the
published literature. For example, one could query Goo-
gle Scholar for all the articles that report a particular
RRID to get a sense of how frequently that resource
appears in publications. Therefore, it is important that
only resources that are used in a study are assigned an
RRID. This should be further clarified in the instructions
to authors.
Which identifiers?
There are many types of and formats of identifiers in
use today (e.g., DOIs, URIs, ARCs), each with varying
amounts of associated infrastructure and use in different
communities. For this project, we elected to use simple
alphanumeric strings and a common syntax in the form
of accession numbers issued by the authoritative
community-based registries. We relied on each registry
to impose the uniqueness constraint at the level of the
entity, for example, ensuring that there was only one
mouse genotype per unique ID, and to ensure standard
metadata by curating each entry. The reuse of authorita-
tive accessions with the RRID prefix provides maximal
flexibility and interoperability and minimal ID churn, while
also provisioning for resource identification.
A frequent question regarding the RRID is why we did
not use a DOI as a unique identifier instead of the Regis-
try Accession number. Part of the reason was cultural:
researchers were used to supplying accession numbers
for GenBank, Gene Expression Omnibus, Protein Data
Bank, etc., and understand this requirement. Part of the
reason is practical: unlike DOIs, accession numbers are
already available for most of the research resources to
be identified in this pilot and did not require special infra-
structure to resolve or cost to issue. Part of the reason is
also philosophical: DOIs are for digital objects, such as
individual articles, that live on the Web and need to be
resolvable. A DOI resolves to a particular article that is
self-contained—it is the object. In contrast, an antibody
does not exist on the Web but is an independent entity
that has data about it scattered across various articles.
There is no single digital record that is the antibody; there
are documents and data about the entity. We note that in
our community we also do not use DOIs to identify peo-
ple, but rather an ORCID, which serves the same purpose
as the RRID.
A case could be made for using DOIs to identify par-
ticular software tools and databases, as they are digital
objects. As discussed in the next section, our prefer-
ence is that DOIs be used to identify the particular
instance used, e.g., the version of data or software and
any supporting workflows, and that the RRID be used
to identify the entity or project referenced. Thus, the
RRID would be used to identify the Protein Databank,
and a PDB identifier or a DOI used to reference the
specific data from the PDB. However, we believe that
as the RRID system is adopted, each community should
set appropriate identifier systems. The RRID syntax is
meant to be simple and generic and could, in theory,
work with any existing authoritative identifier system.
How granular should RRIDs be?
RRIDs are meant to identify research resources at a
fairly high level of granularity. At some of the planning
meetings, there was a push for more granular informa-
tion, e.g., lot and/or batch numbers for antibodies. We
recognize that this level of granularity is likely an impor-
tant factor in determining how a given reagent performs
(Slotta et al., 2014). In our analysis by Vasilevsky et al.
(2013) and in our experience using text-mining, the big-
gest problem is not that authors were not supplying lot
numbers but that they are not even supplying the minimal
identifying information such as catalog numbers. Given
that the catalog numbers themselves do not serve as sta-
ble identifiers, because antibodies are bought and sold
and redistributed by many vendors, we elected to tackle
the problem of identifying the root antibody first, i.e., a
particular clone for a monoclonal antibody or a type of
polyclonal antibody produced by particular protocol. To
illustrate the problem, consider the study by Slotta et al.
(2014) that provided an analysis of the performance of
antibodies to NF-jB-subunit p65, as a follow-up to a simi-
lar study by Herkenham et al. (2011). Both studies per-
formed specificity tests on a variety of antibodies and, as
is common, did not produce concordant results on all of
them. Slotta et al. originally generated the antibody now
commonly known as MAB3026 (AB_2178887) and pro-
vided its provenance: “It was transferred to Boehringer-
Mannheim as Clone 12H11, resold to Roche and finally
bought by Chemicon, and it is now sold as MAB3026.”
They then speculate that a mutation may have crept in at
some point that altered the specificity of the antibody.
However, the discrepancies may also be attributed to the
additional testing of the antibody in new conditions,
revealing problems that had not been apparent during
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the initial applications. The authoritative Antibody Regis-
try identifier (and therefore the RRID) for this antibody
combines these different representations together so
that all references to this antibody can be tracked.
Authors are encouraged in the citation format to include
details about the particular instance of this antibody,
namely, the vendor from which the antibody was pur-
chased and the catalog, batch, and lot numbers. How-
ever, we did not want to overload the ID system to
require assignment of these different lot numbers differ-
ent RRIDs and maintain the mappings. We were also con-
cerned that this would grossly decrease compliance.
For organisms, all of the authors’ “errors” were due
to the allele being reported but not the organism stock
or genotype. The allele ID is not sufficient for identifying
the animal used, as the same allele may be inserted
into different mice of various backgrounds and with
other alleles, and therefore will have different pheno-
typic characteristics. It should also be noted that
authors consulting the MGI database (up to October
2014), which maintains the authoritative mouse nomen-
clature, would be able to search for MGI identifiers for
genes and alleles, but not genotypes. This shows that
authors likely went to MGI to obtain their identifiers
rather than searching the RII portal, but were not able
to find the genotype information and substituted the
allele ID. MGI now searches the genotype information
for all mice, suggesting that authors of newer articles
can now also find the genotype information more easily
at MGI and a tutorial for how to obtain a genotype iden-
tifier from MGI is now posted on the RII portal pages.
Support for genotype identification, and therefore
RRIDs, is planned to also be provided by a new Mon-
arch Initiative phenotyping tool for submission of geno-
type–phenotype data to journals and model organism
databases.
For tools (software and databases), we elected to
identify the root entity and not a granular citation of a
particular software version or database. Our main goal
in the case of software tools and databases was to
track broad patterns of utilization of these resources
(e.g., how many times NeuroMorpho.org was used) and
not particular versions. More complete practices for cit-
ing software and datasets are emerging from recent
efforts like the Joint Declaration of Data Citation princi-
ples (https://www.force11.org/datacitation), the W3C
HCLS dataset description (http://tiny.cc/hcls-data-
desc), the software discovery index (http://softwaredis-
coveryindex.org/), and many others. These groups are
exploring more complete reporting standards for the
individual instances (versions, workflows, virtual
machines) that can be used to reproduce the findings.
We note that the goal of using RRIDs for software tools
was to determine participation rates for authors identi-
fying these resources using the easiest possible solu-
tion, with the longer-term goal including more robust
versioning and archival software practices that would
support reproducibility.
What are the next steps?
The RII is a grassroots effort that took advantage of
existing investments by the NIH to solve a problem
without extensive new infrastructure. The RII is continu-
ing to run and has expanded beyond the initial partici-
pants. We believe that the growth of the initiative
indicates that it fills a need not currently met by our
existing practices and infrastructure.
Should RRIDs be adopted broadly across all of biome-
dicine? We would argue yes, the RRID syntax should
become the standard for reporting on usage of research
resources. We have shown that the requirements for this
type of broad adoption are the availability of comprehen-
sive and authoritative registries for the appropriate enti-
ties, a centralized portal or services that aggregate these
registries into a single search, and the willingness of a
community including journals and publishers to support
this type of reporting. More sophisticated services can be
built to improve and automate authoring and editorial
oversight, but these are not required. The solution is
therefore accessible both to large commercial publishers
and smaller community- or society-based journals.
If RRIDs were to be broadly adopted tomorrow, what
are the outstanding issues regarding implementation
and scalability? The first issue is one of scope. The cur-
rent RII focused on three types of research resources
that were broadly used and a known source of variabili-
ty within experiments. Should all research resources be
similarly identified, i.e., every chemical, instrument,
etc.? We think such an approach would be clumsy and
difficult to implement. We can imagine a future where
all reagents and tools are barcoded and scanned as
they are used in a study. However, as long as humans
are responsible for supplying identifiers, we think that
the effort should focus on certain types of known prob-
lematic entities for which better metadata and ability to
query across articles is required. Given the recent prob-
lems associated with certain cell lines, for example,
these are obvious candidates (ICLAC, 2015). The
advantage of the current system is that it allows com-
munities who have taken the steps to aggregate and
organize resources that are of use to them to agree to
include the RRID syntax and single entry point.
The second issue is governance. We deliberately
designed a decentralized system that gives control of
issuing identifiers to multiple authorities. Such a model
requires some governance, in the form of willingness of
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the authorities to maintain the integrity of any identi-
fiers and links and implementation of a policy regarding
entities that are no longer available. We would also
need some governance to ensure that multiple, uncoor-
dinated authorities are not issuing IDs for the same
research resource and that the IDs assigned to each
entity are unique. The latter constraint is handled by
the centralized aggregation service currently provided
by SciCrunch; however, it may be handled by other
services in the future. Further, the RRID project pro-
motes consistent citation of research resources at a
first level identifiability. We believe that more granular
reporting standards can and should work hand in hand
with the RRIDs and could be coordinated with the
authoritative communities; for example, versioned soft-
ware releases in GitHub.
Some of these governance issues are necessarily
interdependent on issues relating to sustainability. As
we increase participation among journals and resource
providers, it would make sense to spread the cost of
maintenance and development. One thing to consider is
that resolution services can provide advertising for
resource providers as third-party applications are devel-
oped to connect people to resources in different con-
texts (such as in the Elsevier application described
above). We would conjecture that as the number and
types of these applications increase, the need to con-
tribute and therefore help sustain resource registries
will become increasingly advantageous.
We believe that the RRID project lays an important
foundation for creating a type of “universal product
code” (UPC) to help alert the scientific community
when issues are raised about key research resources.
Reagents and tools are not perfect and problems can
arise, as the resources themselves can have issues as
they are tested across various paradigms and systems.
Even when a resource initially performed well, due to
spontaneous mutations in biological resources and
interactions between particular software tools and plat-
forms, problems can arise over time. For example, two
recent articles have published extensive tests showing
that common antibodies for NF-jB show nonspecificity
under some circumstances (Listwak et al., 2013; Slotta
et al., 2014). Many of these antibodies are extensively
used in the literature, but readers of a particular article
have no way of knowing that concerns have been
raised. We have similar examples with software tools
(Gronenschild et al., 2012), datasets (Hupe et al.,
2015) (Button et al., 2013), and genetically modified
animals (Cone et al., 2013). We have an infrastructure
in place, CrossMark, to alert readers of a particular arti-
cle that an addendum or erratum has been posted. The
RRID system can serve as the basis for a similar sys-
tem for research resources.
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